Differentiation, maturation, and survival of dendritic cells by osteopontin regulation

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 1, 2005, Pages 206-212

  Kawamura, Kodai ^a   Iyonaga, Kazuhiro ^a   Ichiyasu, Hidenori ^a   Nagano, Junji ^a   Suga, Moritaka ^a   Sasaki, Yutaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OSTEOPONTIN; OSTEOPONTIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MONOCYTE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; MONOCYTES; OSTEOPONTIN; SIALOGLYCOPROTEINS; STEM CELLS;

EID: 12544251243     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.1.206-212.2005     Document Type: Article

References (36)

1. Ahn, J. H., Y. Lee, C. Jeon, S. J. Lee, B. H. Lee, K. D. Choi, and Y. S. Bae. 2002. Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 100:1742-1754.
2. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313.
3. Ashkar, S., G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287:860-864.
4. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
5. Behrend, E. I., A. M. Craig, S. M. Wilson, D. T. Denhardt, and A. F. Chambers. 1994. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res. 54:832-837.
6. Bertho, N., B. Drenou, B. Laupeze, C. L. Berre, L. Amiot, J.-M. Grosset, O. Fardel, D. Charron, N. Mooney, and R. Fauchet. 2000. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/ monocytic APC. J. Immunol. 164:2379-2385.
7. Brown, L. F., B. Berse, L. Van de Water, A. Papadopoulos-Sergiou, C. A. Perruzzi, E. J. Manseau, H. F. Dvorak, and D. R. Senger. 1992. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell 3:1169-1180.
8. Chiocchetti, A., M. Indelicato, T. Bensi, R. Mesturini, M. Giordano, S. Sametti, L. Castelli, F. Bottarel, M. C. Mazzarino, L. Garbarini, F. Giacopelli, G. Valesini, C. Santoro, I. Dianzani, U. Ramenghi, and U. Dianzani. 2004. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 103:1376-1382.
9. Denhardt, D. T., M. Noda, A. W. O'Regan, D. Pavlin, and J. S. Berman. 2001. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Investig. 107: 1055-1061.
10. de Saint-Vis, B., J. Vincent, S. Vandenabeele, B. Vanbervliet, J. J. Pin, S. Ait-Yahia, S. Patel, M. G. Mattei, J. Banchereau, S. Zurawski, J. Davoust, C. Caux, and S. Lebecque. 1998. A novel lysosome-associated membrane glycoprotein. DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9:325-336.
11. Haegel-Kronenberger, H., H. de la Salle, A. Bohbot, F. Oberling, J.-P. Cazenave, and D. Hanau. 1998. Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells. J. Immunol. 161:3902-3911.
12. Iyonaga, K., K. M. McCarthy, and E. E. Schneeberger. 2002. Dendritic cells and the regulation of a granulomatous immune response in the lung. Am. J. Respir. Cell Mol. Biol. 26:671-679.
13. Katagiri, Y. U., J. Sleeman, H. Fujii, P. Herrlich, H. Hotta, K. Tanaka, S. Chikuma, H. Yagita, K. Okumura, M. Murakami, I. Saiki, A. F. Chambers, and T. Uede. 1999. CD44 variants but not CD44s cooperate with β1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59:219-226.
14. Khan, S. A., C. A. Lopez-Chua, J. Zhang, L. W. Fisher, E. S. Sorensen, and D. T. Denhardt. 2002. Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors. J. Cell. Biochem. 85:728-736.
15. Koguchi, Y., K. Kawakami, K. Uezu, K. Fukushima, S. Kon, M. Maeda, A. Nakamoto, I. Owan, M. Kuba, N. Kudeken, M. Azuma, S. Yara, T. Shinzato, F. Higa, M. Tateyama, J.-I. Kadota, H. Mukae, S. Kohno, T. Uede, and A. Saito. 2003. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am. J. Respir. Crit. Care Med. 167:1355-1359.
16. 2 via their high basal and inducible levels of catalase activity. J. Biol. Chem. 276:24360-24364.
17. Lin, Y.-H., C.-J. Huang, J.-R. Chao, S.-T. Chen, S.-F. Lee, J. J.-Y. Yen, and H.-F. Yang-Yen. 2000. Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol. Cell. Biol. 20:2734-2742.
18. Mazzali, M., T. Kipari, V. Ophascharoensuk, J. A. Wesson, R. Johnson, and J. Hughes. 2002. Osteopontin-a molecule for all seasons. QJM 95:3-13.
19. Nau, G. J., G. L. Chupp, J.-F. Emile, E. Jouanguy, J. S. Berman, J.-L. Casanova, and R. A. Young. 2000. Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection. Am. J. Pathol. 157:37-42.
20. Nau, G. J., P. Guilfoile, G. L. Chupp, J. S. Berman, S. J. Kim, H. Kornfeld, and R. A. Young. 1997. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc. Natl. Acad. Sci. USA 94:6414-6419.
21. Nau, G. J., L. Liaw, G. L. Chupp, J. S. Berman, B. L. M. Hogan, and R. A. Young. 1999. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect. Immun. 67:4223-4230.
22. Ophascharoensuk, V., C. M. Giachelli, K. Gordon, J. Hughes, R. Pichler, P. Brown, L. Liaw, R. Schmidt, S. J. Shankland, C. E. Alpers, W. G. Couser, and R. J. Johnson. 1999. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int. 56:571-580.
23. O'Regan, A., and J. S. Berman. 2000. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int. J. Exp. Pathol. 81:373-390.
24. O'Regan, A. W., G. L. Chupp, J. A. Lowry, M. Goetschkes, N. Mulligan, and J. S. Berman. 1999. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J. Immunol. 162:1024-1031.
25. O'Regan, A. W., J. M. Hayden, S. Body, L. Liaw, N. Mulligan, M. Goetschkes, and J. S. Berman. 2001. Abnormal pulmonary granuloma formation in osteopontin-deficient mice. Am. J. Respir. Crit. Care Med. 164:2243-2247.
26. Pollack, S. B., P. A. Linnemeyer, and S. Gill. 1994. Induction of osteopontin mRNA expression during activation of murine NK cells. J. Leukoc. Biol. 55:398-400.
27. Reis e Sousa, C. 2001. Dendritic cells as sensors of infection. Immunity 14:495-498.
28. Rittling, S. R., and D. T. Denhardt. 1999. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp. Nephrol. 7:103-113.
29. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kampgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Methods 196:137-151.
30. Sallusto, F., and A. Lanzaveccbia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
31. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
32. Termeer, C., H. Johannsen, T. Braun, A. Renkl, T. Ahrens, R. W. Denfeld, M. B. Lappin, J. M. Weiss, and J. C. Simon. 2001. The role of CD44 during CD40 ligand-induced dendritic cell clustering and maturation. J. Leukoc. Biol. 70:715-722.
33. Tsuchiya, T., K. Chida, T. Suda, E. E. Schneeberger, and H. Nakamura. 2002. Dendritic cell involvement in pulmonary granuloma formation elicited by bacillus Calmette-Guerin in rats. Am. J. Respir. Crit. Care Med. 165: 1640-1646.
34. Weiss, J. M., A. C. Renkl, C. S. Maier, M. Kimmig, L. Liaw, T. Ahrens, S. Kon, M. Maeda, H. Hotta, T. Uede, and J. C. Simon. 2001. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 194: 1219-1229.
35. Weiss, J. M., J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxis, N. Howells, M. Hofmann, G. Kohler, E. Schopf, H. Ponta, P. Herrlich, and J. C. Simon. 1997. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137:1137-1147.
36. Yoneyama, H., K. Matsuno, Y. Zhang, M. Murai, M. Itakura, S. Ishikawa, G. Hasegawa, M. Naito, H. Asakura, and K. Matsushima. 2001. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 193:35-49.